Metaverse program aims to boost quality of life for cancer survivors
NCT ID NCT07362823
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new health education program using a virtual 'metaverse' to help colorectal cancer survivors improve their quality of life and adopt healthier lifestyles. The program includes online lessons, immersive virtual interactions, and group support via WeChat. Researchers will compare this approach to standard paper-based education in 174 adults who have had surgery for colorectal cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 174 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients with first diagnosed colorectal cancer who have undergone radical surgical treatment 2. Aged ≥18 years old and non-pregnant 3. Have basic communication, reading and comprehension abilities, and can proficiently use smartphones and WeChat 4. Voluntarily sign the informed consent form and promise to cooperate in completing all interventions and follow-up assessments Exclusion Criteria: 1. Patients with other types of malignant tumors 2. Patients with incompletely resected tumors or distant metastases 3. Patients with dysfunction of important organs such as heart, liver and kidney, or with unstable/rapidly deteriorating conditions 4. Patients with severe cognitive impairment who cannot communicate normally and cooperate with the intervention
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer survivors are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a computer model read MRI scans to predict which liver cancer patients will relapse?
- Can a lab test tell which chemo works for colon cancer?
- Can MRI and computer models predict how well cancer drugs reach tumors?
- Gut bacteria may hold clues to why some cancer treatments work better
- Burning the edges: a new way to stop colon polyps from coming back
- Missed Follow-Up colonoscopies: do they raise the risk of advanced growths?